Literature DB >> 12140514

Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy.

Hanh Vu Nghiem1, Isaac R Francis, Robert Fontana, Hero Hussain, Joel F Platt, Ellen Higgins, Robert L Bree.   

Abstract

A retrospective review of the computed tomography (CT) findings of patients with hypervascular liver tumors (26 hepatocellular carcinomas and 2 metastases [1 periampullary carcinoma and 1 neuroendocrine tumor]) who underwent percutaneous ultrasound-guided radiofrequency ablation (RFA) was performed. CT images consisted of nonenhanced and dual-phase contrast-enhanced helical CT images performed on a multidetector CT scan. Findings indicative of adequate tumor ablation on multidetector CT scanwere complete nonenhancement of the treated tumor with or without faint, thin, peripheral rim enhancement. Ablated lesions that showed complete nonenhancement on initial and subsequent follow-up CT examinations either remained stable or became progressively smaller. Thick rim or nodular peripheral enhancement was indicative of tumor residual or recurrence.

Entities:  

Mesh:

Year:  2002        PMID: 12140514     DOI: 10.1067/cdr.2002.125400

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  3 in total

1.  Analysis of iodinated contrast delivered during thermal ablation: is material trapped in the ablation zone?

Authors:  Po-Hung Wu; Chris L Brace
Journal:  Phys Med Biol       Date:  2016-07-25       Impact factor: 3.609

2.  Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.

Authors:  Cheng William Hong; Lucy Chow; Evrim B Turkbey; Riccardo Lencioni; Steven K Libutti; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2015-07-31       Impact factor: 2.740

3.  Dual-energy CT after radiofrequency ablation of liver, kidney, and lung lesions: a review of features.

Authors:  Frederik Vandenbroucke; Steven Van Hedent; Gert Van Gompel; Nico Buls; Gordon Craggs; Jef Vandemeulebroucke; Pablo R Ros; Johan de Mey
Journal:  Insights Imaging       Date:  2015-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.